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Background
Malignant hyperthermia (MH) is a complication of
anaesthesia appearing as an acute potentially lethal
hypermetabolic state in people carrying a genetic anom-
aly expressed in the skeletal muscle. MH susceptibility
can be diagnosed by in vitro contracture test (IVCT) with
halothane and caffeine requiring muscular biopsy, or by
looking for the MH mutations directly in DNA extracted
from the blood. Studies showed an influence of the type
of mutation (genotype) on the various expressions (phe-
notypes) of the MH susceptibility. The aims of this study
are to look for any correlation between the presence of a
MH mutation and 1) the severity of the anesthetic com-
plication and 2) the force of the contractures observed in
the IVCT.
Materials and methods
Observational analytical retrospective anonymized study
based on the informations contained in the Lille MH
Database. The criteria of inclusion were: 1) anesthetic pro-
bands classified as MHS according to the IVCT and/or the
presence of a MH mutation in the RYR1 gene in at least
one family member and 2) existence of sufficient clinical
information concerning the crisis. The severity of the MH
crisis was classified as: death, survival after stay in inten-
sive care unit ICU, survival without stay in ICU. The
results of the IVCT: maximal force of contracture at
halothane 2%, caffeine 2mmol/L, halothane 3%. The statis-
tical analysis was carried out with a test of Chi-2 for the
comparisons of frequency and a test of Mann Whitney for
the nonparametric variables with p<0,05 significant.
Results
92 MHS probands were included in the study: 63 men
(68%) and 29 women (32%) over a period going from
1964 to 2013. The age at the moment of the crisis is
18,9 years (DS 13,3). Mutations were found in 59
families (64%) including 53 causal mutations (58%) and
6 probable (6%). No significant difference was observed
in the degree of severity between the 2 populations. The
force of contracture of the IVCT was significantly higher
in the group with MH (Table 1).
Conclusions
In this study, the severity of the MH crisis is not related
to the presence of MH mutations. It is well known that
the severity is more dependent on environmental factors,
age of the crisis, exposure time to the volatile anesthetic
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Table 1 Severity of malignant hyperthermia reaction and
force of contracture of the In-vitro-contracture test
N=92 No mutation Mutation p
Severity n=33 n=59
death 29 10 (35%) 19 (65%) 0,85*(NS)
Alive stay ICU 28 5 (18%) 23 (82%) 0,15*(NS)
Alive no stay ICU 35 18 (52%) 17 (48%) 0,17*(NS)
Force of contracture Mean+/-SD Mean+/-SD
H2% g 0,99+/-1,02 2,46+/-1,86 0,00005**
Caf 2mmol g 0,58+/-0,58 1,29+/-0,97 0,00002**
H3% g 1,43+/-1,33 4,2+/-2,43 0,0000003**
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agents, administration of dantrolene. On the other hand,
the presence of a MH mutation in gene RYR1 modifies
the muscular phenotype since the force of contracture in
the IVCT is significantly more important in this group.
These results support the genetic heterogeneity of the
disease.
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